A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Meta-analysis in clinical trials
1986 • 36,193 citations
Development of a Rating Scale for Primary Depressive Illness
1967 • 8,216 citations
Physicians Desk Reference
1994 • 2,653 citations
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
1992 • 1,582 citations
"Compendium of pharmaceuticals and specialties".
1983 • 413 citations
Treatment of major depression
1993 • 255 citations
Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies
1991 • 242 citations
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
1994 • 162 citations
The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population.
1990 • 134 citations
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
1994 • 130 citations
Placebo-Controlled Trial of Venlafaxine for the Treatment of Major Depression
1991 • 120 citations
Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
1993 • 34 citations
Meta-analysis for combining Bayesian probabilities
1991 • 34 citations
Rank-order Stability Analysis (ROSA)
1995 • 15 citations
The Formulary Decision-Making Process in a Health Maintenance Organisation Setting
1994 • 14 citations
Cumulative mean change procedure: Application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression
1994 • 8 citations
The Emerging Field of Oral Pharmaceuticals
1994 • 2 citations